ARCUTIS BIOTHERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$32.07
+0.31%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+26.8%
3 months
+23.6%
6 months
+37.3%
1 year
+28.7%
Year to date
+10.4%
52-week range
$19.50 – $32.82
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$4.03B
P/E
141.3
P/B
18.3
P/S
8.7
Revenue
$463.98M
Net income
$28.52M
Diluted EPS
0.21
Gross margin
91.10%
Net margin
6.10%
Return on equity
15.10%
Total debt
$114.14M
Cash
$34.43M
Free cash flow
$39.15M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $129.86M | $15.01M | 91.60% | 11.60% | $12.48M |
| Mar 31, 2026 | $105.4M | -$11.3M | 90.70% | -10.70% | $2.24M |
| Dec 31, 2025 | $129.5M | $17.4M | 91.00% | 13.40% | $26.19M |
| Sep 30, 2025 | $99.22M | $7.41M | 91.20% | 7.50% | -$1.75M |
| Jun 30, 2025 | $81.5M | -$15.89M | 90.80% | -19.50% | $246K |
| Mar 31, 2025 | $65.85M | -$25.06M | 86.60% | -38.10% | -$30.99M |
| Dec 31, 2024 | $71.36M | -$10.79M | 90.30% | -15.10% | -$748K |
| Sep 30, 2024 | $44.76M | -$41.54M | 87.70% | -92.80% | -$34.83M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ARQT news
All market newsNo ticker-linked stories are in the current archive.